Giant Cell Arteritis vs Takayasu Arteritis: How to Tell Them Apart
Giant cell arteritis and Takayasu arteritis are the two classic large-vessel vasculitides, both showing a female predominance and markedly elevated inflammatory markers (ESR/CRP). The core axis that separates them is patient age and the vascular territory involved: GCA strikes older adults (>50) with cranial artery involvement threatening vision, while Takayasu affects young women (<40) with aortic branch stenoses producing pulse and blood pressure differentials.
How to tell them apart
| Feature | Giant Cell Arteritis (GCA) | Takayasu Arteritis |
|---|---|---|
| Age | >50 years, usually >70; almost never younger | <40 years, usually 15-30 |
| Vessels affected | Temporal, ophthalmic, and vertebral arteries; can also affect the aorta | Aorta and its major branches (subclavian, carotid, renal) |
| Key symptoms | New headache, scalp tenderness, jaw claudication, polymyalgia rheumatica symptoms | Arm claudication, syncope/lightheadedness, absent pulses, BP differential, stroke |
| Signature exam finding | Scalp/temporal artery tenderness | 'Pulseless disease' — diminished upper extremity pulses and blood pressure differentials between limbs |
| Urgent concern | Irreversible vision loss from ophthalmic artery involvement — an ophthalmologic emergency | Stroke, limb ischemia, and renovascular hypertension |
| Diagnostic modality | Temporal artery biopsy (skip lesions possible) | CTA or MRA showing stenoses and aneurysms |
| Additional lab finding | Markedly elevated ESR/CRP | Elevated ESR/CRP plus anemia |
| Treatment | High-dose glucocorticoids started immediately, before biopsy if vision is threatened | Glucocorticoids plus immunosuppressives (methotrexate, tocilizumab) |
The reasoning
Start with the patient's age — it is the single most powerful discriminator. An elderly patient (>50, often >70) with a new headache, scalp tenderness, jaw claudication, and a markedly elevated ESR has GCA until proven otherwise, and treatment must begin immediately because vision loss is irreversible. A young woman (<40) with arm claudication, syncope, diminished pulses, or blood pressure differences between limbs has Takayasu, confirmed by CTA or MRA showing arterial stenoses and aneurysms. Both share female predominance and elevated inflammatory markers, so lean on age, the vascular territory (cranial vs aortic branch), and the signature findings (jaw claudication/vision threat vs pulseless disease/BP differential) to arbitrate. In GCA, do not let a negative biopsy or a pending biopsy delay steroids when suspicion is high.
Key tests
- Temporal artery biopsy: diagnostic for GCA (may show skip lesions); not the diagnostic test for Takayasu, where cranial arteries are not the target.
- CT or MR angiography: in Takayasu reveals stenoses and aneurysms of the aorta and its branches; not the primary diagnostic approach in GCA, which relies on temporal artery biopsy.
- ESR/CRP: markedly elevated in GCA; also elevated in Takayasu but classically accompanied by anemia.
- Bilateral blood pressure and pulse examination: reveals BP differentials and diminished/absent upper extremity pulses in Takayasu ('pulseless disease'); typically normal peripheral pulses in GCA.
What they share
- Large-vessel vasculitis with a female predominance
- Elevated inflammatory markers (ESR and CRP)
- Both can involve the aorta
- Both are treated with glucocorticoids
Pitfalls
- Waiting for temporal artery biopsy results before starting high-dose steroids in GCA — untreated disease can cause permanent vision loss, and biopsy findings persist for a time after steroids are begun.
- A negative temporal artery biopsy does not exclude GCA because of skip lesions; continue treatment if clinical suspicion is high.
- Both conditions can involve the aorta and both have female predominance and elevated ESR/CRP, so these overlapping features cannot distinguish them — anchor on age and vessel distribution.
- Overlooking bilateral BP/pulse measurement in a young woman, thereby missing the pulseless disease and BP differential that point to Takayasu.
Practice this the way the exam tests it — on branching cases where your decisions shape the patient.